The New England Compounding Pharmacy announced it would recall its products currently in circulation distributed from its facility in Framingham, Mass.
The recall was sparked by a potential risk of contamination, which is being investigated by the U.S. Food and Drug Administration, Center for Disease Control and Prevention and the Massachusetts Board of Registration Pharmacy.
The recall is being taken as a precautionary measure and the company has asked providers to stop using the product immediately.
More Articles on Pain Management:
Dr. Brian Goodman Joins Mercy Clinic River Valley
Florida Prescription Drug Database Underused After 1 Year
Prospira PainCare Acquires Two Pain Practices
The recall was sparked by a potential risk of contamination, which is being investigated by the U.S. Food and Drug Administration, Center for Disease Control and Prevention and the Massachusetts Board of Registration Pharmacy.
The recall is being taken as a precautionary measure and the company has asked providers to stop using the product immediately.
More Articles on Pain Management:
Dr. Brian Goodman Joins Mercy Clinic River Valley
Florida Prescription Drug Database Underused After 1 Year
Prospira PainCare Acquires Two Pain Practices